KOBO BIOTECH LIMITED (KOBO.BO)
INR 2.68
(-3.6%)
INR 2.68
(-3.6%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -8.57 Million INR | 7.75% |
| 2022 | -14.81 Million INR | -105.5% |
| 2021 | -104.85 Million INR | 879.75% |
| 2020 | -27.53 Million INR | 15.4% |
| 2019 | -26.07 Million INR | 12.91% |
| 2018 | -29.94 Million INR | 2.87% |
| 2017 | -29.81 Million INR | 21.68% |
| 2016 | 19.5 Million INR | -201.42% |
| 2015 | 38.81 Million INR | 139.09% |
| 2014 | -68.6 Million INR | -42.83% |
| 2013 | -6.74 Million INR | -115.91% |
| 2012 | 411.38 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.35 Million INR | -37.04% |
| 2023 Q1 | -2.28 Million INR | 71.12% |
| 2023 Q4 | -2.45 Million INR | -20.45% |
| 2023 Q3 | -2.03 Million INR | -3.83% |
| 2023 Q2 | -1.95 Million INR | 14.15% |
| 2023 FY | - INR | 7.75% |
| 2022 Q1 | -3.3 Million INR | 96.42% |
| 2022 FY | - INR | -105.5% |
| 2022 Q4 | -7.9 Million INR | -376.89% |
| 2022 Q3 | -1.65 Million INR | 20.98% |
| 2022 Q2 | -2.09 Million INR | 36.63% |
| 2021 Q4 | -92.35 Million INR | -2929.92% |
| 2021 FY | - INR | 879.75% |
| 2021 Q3 | -3.04 Million INR | 56.4% |
| 2021 Q2 | -6.99 Million INR | -166.12% |
| 2021 Q1 | -2.62 Million INR | -21.95% |
| 2020 Q2 | -6.75 Million INR | -25.58% |
| 2020 Q4 | -2.15 Million INR | 68.0% |
| 2020 FY | - INR | 15.4% |
| 2020 Q1 | -5.37 Million INR | 14.15% |
| 2020 Q3 | -6.73 Million INR | 0.27% |
| 2019 Q4 | -6.26 Million INR | -13.03% |
| 2019 Q2 | -6.78 Million INR | 1.76% |
| 2019 FY | - INR | 12.91% |
| 2019 Q1 | -6.9 Million INR | 9.14% |
| 2019 Q3 | -5.53 Million INR | 18.3% |
| 2018 Q3 | -6.29 Million INR | -4.26% |
| 2018 Q2 | -6.03 Million INR | 22.2% |
| 2018 Q1 | -7.76 Million INR | -1.4% |
| 2018 FY | - INR | 2.87% |
| 2018 Q4 | -7.59 Million INR | -20.64% |
| 2017 Q2 | -9.98 Million INR | -47.71% |
| 2017 Q3 | -6.23 Million INR | 37.6% |
| 2017 Q1 | -6.75 Million INR | 2.71% |
| 2017 FY | - INR | 21.68% |
| 2017 Q4 | -7.65 Million INR | -22.88% |
| 2016 Q1 | -9.54 Million INR | 86.19% |
| 2016 FY | - INR | -201.42% |
| 2016 Q4 | -6.94 Million INR | 43.66% |
| 2016 Q3 | -12.33 Million INR | -20.05% |
| 2016 Q2 | -10.27 Million INR | -7.58% |
| 2015 Q1 | 60.68 Million INR | 316.76% |
| 2015 Q2 | 64.25 Million INR | 5.89% |
| 2015 FY | - INR | 139.09% |
| 2015 Q4 | -69.14 Million INR | -460.68% |
| 2015 Q3 | -12.33 Million INR | -119.19% |
| 2014 Q1 | -20.88 Million INR | 0.0% |
| 2014 FY | - INR | -42.83% |
| 2014 Q3 | -15.71 Million INR | 29.65% |
| 2014 Q4 | -27.99 Million INR | -78.21% |
| 2014 Q2 | -22.33 Million INR | -6.91% |
| 2013 FY | - INR | -115.91% |
| 2012 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | 109.456% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 110.377% |
| Bacil Pharma Limited | -569.32 Thousand INR | -1405.832% |
| Beryl Drugs Limited | 26.63 Million INR | 132.182% |
| Cian Healthcare Limited | 122.56 Million INR | 106.995% |
| Colinz Laboratories Limited | 5.42 Million INR | 257.94% |
| Concord Drugs Limited | 40.52 Million INR | 121.157% |
| Deccan Health Care Limited | 37.5 Million INR | 122.858% |
| Gennex Laboratories Limited | 219.35 Million INR | 103.908% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 153.996% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | 172.115% |
| Kerala Ayurveda Limited | 70.78 Million INR | 112.111% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 101.404% |
| Mercury Laboratories Limited | 101.18 Million INR | 108.472% |
| Panchsheel Organics Limited | 189.36 Million INR | 104.527% |
| Parmax Pharma Limited | 22.93 Million INR | 137.375% |
| Parnax Lab Limited | 243.59 Million INR | 103.519% |
| Patidar Buildcon Limited | -5.52 Million INR | -55.139% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 93.046% |
| Phaarmasia Limited | -1.58 Million INR | -441.909% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 131.526% |
| Sastasundar Ventures Limited | -203.51 Million INR | 95.787% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 109.632% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 119.134% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 103.373% |
| Sunil Healthcare Limited | 93.07 Million INR | 109.21% |
| Syschem (India) Limited | 70.4 Million INR | 112.177% |
| Trident Lifeline Limited | 102.69 Million INR | 108.348% |
| Transchem Limited | 56.61 Million INR | 115.144% |
| Tyche Industries Limited | 128.2 Million INR | 106.687% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 102.216% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 110.179% |
| Zenith Healthcare Limited | 4.98 Million INR | 271.872% |
| Zenotech Laboratories Limited | 172.64 Million INR | 104.966% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | 1442.144% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | 174.007% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 151.901% |
| MedPlus Health Services Limited | 3.94 Billion INR | 100.218% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 109.788% |
| Smruthi Organics Limited | 120.31 Million INR | 107.126% |
| Trimurthi Limited | -2.47 Million INR | -245.893% |
| Zenlabs Ethica Limited | 27.09 Million INR | 131.639% |
| Makers Laboratories Limited | 25.81 Million INR | 133.213% |
| Lactose (India) Limited | 201.22 Million INR | 104.26% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 94.325% |
| Roopa Industries Limited | 55.7 Million INR | 115.391% |
| PANJON LTD. | 4.08 Million INR | 309.66% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 55.002% |
| Anuh Pharma Limited | 878.5 Million INR | 100.976% |
| Crestchem Limited | 30.33 Million INR | 128.262% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 20.752% |
| PRAVEG LIMITED | 321.43 Million INR | 102.667% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 102.204% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 103.958% |
| Norris Medicines Limited | -1.78 Million INR | -380.51% |
| Denis Chem Lab Limited | 224.84 Million INR | 103.813% |
| Veerhealth Care Limited | 15.99 Million INR | 153.598% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 102.269% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 91.086% |
| Godavari Drugs Limited | 134.62 Million INR | 106.368% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -2011.576% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 105.026% |
| Vivanza Biosciences Limited | 11.2 Million INR | 176.517% |
| Medi-Caps Limited | 4.77 Million INR | 279.69% |
| DECIPHER LABS LIMITED | -2.72 Million INR | -215.184% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 101.91% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 101.032% |
| Bharat Parenterals Limited | 265.74 Million INR | 103.226% |
| BDH Industries Limited | 124.27 Million INR | 106.899% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 73.523% |
| Coral Laboratories Limited | 227.07 Million INR | 103.775% |
| Evoq Remedies Limited | 6.18 Million INR | 238.543% |
| Trinity League India Limited | -26.25 Million INR | 67.345% |
| Natural Capsules Limited | 219.9 Million INR | 103.899% |
| Auro Laboratories Limited | 121.73 Million INR | 107.042% |